Common patenting tactic by drug companies may be illegal, FTC says

By The New York Times
| September 14, 2023

Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

One of the most important elements of a company’s success is also one of the least tangible —culture. ...